Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) Meeting Abstract
| Authors: | Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; Dahi, P. B.; Koehne, G.; Tamari, R.; Wang, P.; Giese, R.; Carlow, D.; Giralt, S. A.; Landau, H. |
| Abstract Title: | Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) |
| Meeting Title: | 2018 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 24 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2018 Feb 21-25 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-03-01 |
| Start Page: | S127 |
| End Page: | S128 |
| Language: | English |
| ACCESSION: | WOS:000425476000157 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2017.12.072 |
| Notes: | Meeting Abstract: 153 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos |
